Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Exponent (EXPO) Shares Outstanding (Weighted Average): 2010-2025

Historic Shares Outstanding (Weighted Average) for Exponent (EXPO) over the last 16 years, with Oct 2025 value amounting to $50.5 million.

  • Exponent's Shares Outstanding (Weighted Average) fell 0.45% to $50.5 million in Q4 2025 from the same period last year, while for Sep 2019 it was $51.9 million, marking a year-over-year decrease of 0.23%. This contributed to the annual value of $50.8 million for FY2025, which is 0.28% up from last year.
  • Per Exponent's latest filing, its Shares Outstanding (Weighted Average) stood at $50.5 million for Q4 2025, which was down 0.49% from $50.8 million recorded in Q3 2025.
  • Exponent's Shares Outstanding (Weighted Average)'s 5-year high stood at $52.1 million during Q3 2021, with a 5-year trough of $50.5 million in Q4 2025.
  • Its 3-year average for Shares Outstanding (Weighted Average) is $50.7 million, with a median of $50.7 million in 2024.
  • As far as peak fluctuations go, Exponent's Shares Outstanding (Weighted Average) climbed by 1.12% in 2021, and later fell by 2.83% in 2023.
  • Exponent's Shares Outstanding (Weighted Average) (Quarterly) stood at $52.1 million in 2021, then decreased by 2.83% to $50.6 million in 2022, then dropped by 0.03% to $50.6 million in 2023, then declined by 0.23% to $50.7 million in 2024, then fell by 0.45% to $50.5 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $50.5 million for Q4 2025, versus $50.8 million for Q3 2025 and $50.8 million for Q2 2025.